TPST Earnings

Quarterly EPS
$-5.32
Q3 2024
$-4.38
Q4 2024
$-3.16
Q1 2025
$-2.07
Q2 2025
$-0.79
Q3 2025
$-0.82
Q4 2025
$-2.53
Q1 2026
$-0.34
Q2 2026
Latest RevenueN/A
Latest Net Income-5244000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.340-5244000+83.6%
Q1 2026-$2.530-27696000+19.9%
Q4 2025-$0.820-4021000+81.3%
Q3 2025-$0.790-3511000+85.2%
Q2 2025-$2.070-7870000+62.5%
Q1 2025-$3.160-10860000+31.6%
Q4 2024-$4.380-13813000+11.5%
Q3 2024-$5.320-10556000+14.7%
Q2 2024-$5.520-9570000
Q1 2024-$4.620-7904000
Q4 2023-$4.950-7488000
Q3 2023-$6.240-6786000
Tempest Therapeutics (TPST) — Earnings